Header Logo

Connection

FILIP JANKU to Aniline Compounds

Back to Details
This is a "connection" page, showing publications FILIP JANKU has written about Aniline Compounds.
FILIP JANKU
Connection Strength
0.176
Aniline Compounds
  1. Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors. Clin Cancer Res. 2021 05 15; 27(10):2723-2733.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.